| HIT: linking herbal active ingredients to targets H Ye, L Ye, H Kang, D Zhang, L Tao, K Tang, X Liu, R Zhu, Q Liu, ... Nucleic acids research 39 (suppl_1), D1055-D1059, 2010 | 332 | 2010 |
| Construction of drug network based on side effects and its application for drug repositioning H Ye, Q Liu, J Wei PloS one 9 (2), e87864, 2014 | 128 | 2014 |
| Estrogenic Activity Data Extraction and in Silico Prediction Show the Endocrine Disruption Potential of Bisphenol A Replacement Compounds HW Ng, M Shu, H Luo, H Ye, W Ge, R Perkins, W Tong, H Hong Chemical research in toxicology 28 (9), 1784-1795, 2015 | 79 | 2015 |
| Machine learning methods for predicting HLA-peptide binding activity H Luo, H Ye, HW Ng, L Shi, W Tong, DL Mendrick, H Hong Bioinformatics and biology insights 9, BBI. S29466, 2015 | 76 | 2015 |
| Drug repositioning through network pharmacology HY Jia Wei, Kailin Tang, Ritchie Feuers, Huixiao Hong Current Topics in Medicinal Chemistry 16 (30), 2016 | 73 | 2016 |
| Development and validation of decision forest model for estrogen receptor binding prediction of chemicals using large data sets HW Ng, SW Doughty, H Luo, H Ye, W Ge, W Tong, H Hong Chemical research in toxicology 28 (12), 2343-2351, 2015 | 53 | 2015 |
| Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival SK Qin, Q Li, J Ming Xu, J Liang, Y Cheng, Y Fan, J Jiang, H Ye, H Tao, ... Cancer Science 111 (11), 4218-4231, 2020 | 52 | 2020 |
| Assessment of tumor mutation burden calculation from gene panel sequencing data Z Xu, J Dai, D Wang, H Lu, H Dai, H Ye, J Gu, S Chen, B Huang OncoTargets and therapy, 3401-3409, 2019 | 48 | 2019 |
| Towards a bioinformatics analysis of anti-Alzheimer’s herbal medicines from a target network perspective Y Sun, R Zhu, H Ye, K Tang, J Zhao, Y Chen, Q Liu, Z Cao Briefings in bioinformatics 14 (3), 327-343, 2013 | 47 | 2013 |
| Alignment of short reads: a crucial step for application of next-generation sequencing data in precision medicine H Ye, J Meehan, W Tong, H Hong Pharmaceutics 7 (4), 523-541, 2015 | 46 | 2015 |
| A 6-year study of complicated urinary tract infections in southern China: prevalence, antibiotic resistance, clinical and economic outcomes X Li, Y Chen, W Gao, H Ye, Z Shen, Z Wen, J Wei Therapeutics and clinical risk management, 1479-1487, 2017 | 45 | 2017 |
| Exploring the mechanism of flavonoids through systematic bioinformatics analysis T Qiu, D Wu, LL Yang, H Ye, Q Wang, Z Cao, K Tang Frontiers in pharmacology 9, 361101, 2018 | 43 | 2018 |
| Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer L Cai, H Bai, J Duan, Z Wang, S Gao, D Wang, S Wang, J Jiang, J Han, ... Journal for Immunotherapy of Cancer 7, 1-11, 2019 | 34 | 2019 |
| DPDR-CPI, a server that predicts drug positioning and drug repositioning via chemical-protein interactome H Luo, P Zhang, XH Cao, D Du, H Ye, H Huang, C Li, S Qin, C Wan, L Shi, ... Scientific reports 6 (1), 35996, 2016 | 29 | 2016 |
| Ranking novel cancer driving synthetic lethal gene pairs using TCGA data H Ye, X Zhang, Y Chen, Q Liu, J Wei Oncotarget 7 (34), 55352, 2016 | 28 | 2016 |
| Potential metabolic mechanism of girls' central precocious puberty: a network analysis on urine metabonomics data L Yang, K Tang, Y Qi, H Ye, W Chen, Y Zhang, Z Cao BMC systems biology 6, 1-9, 2012 | 28 | 2012 |
| Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysis H Luo, H Ye, HW Ng, L Shi, W Tong, W Mattes, D Mendrick, H Hong BMC bioinformatics 16, 1-9, 2015 | 26 | 2015 |
| A pathway profile-based method for drug repositioning H Ye, LL Yang, ZW Cao, KL Tang, YX Li Chinese Science Bulletin 57, 2106-2112, 2012 | 23 | 2012 |
| sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides H Luo, H Ye, HW Ng, S Sakkiah, DL Mendrick, H Hong Scientific reports 6 (1), 32115, 2016 | 21 | 2016 |
| Benchmarking HLA genotyping and clarifying HLA impact on survival in tumor immunotherapy X Li, C Zhou, K Chen, B Huang, Q Liu, H Ye Molecular Oncology 15 (7), 1764-1782, 2021 | 18 | 2021 |
